Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
Daimler AG50,7250,730,20
16.12.2019 14:27:05
Indexy online
AD Index online
AD Index online

  • 13.12.2019
Baxter Intl (BAX, NY Consolidated)
Závěr k 13.12.2019 Změna (%) Změna (USD) Objem obchodů (ks)
83,96 0,54 0,45 1 836 636
Premarket16.12.2019 13:00:00
Poslední obchod Nákup / Prodej Změna (%) Změna (USD) Objem obchodů (ks)
85,00 78,65 86,50 1,24 1,04 1
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

  • Poslední aktualizace: 16.12.2019
Popis společnosti
Obecné informace
Název společnostiBaxter International Inc
Kmenové akcie:Ordinary Shares
Poslední známé roční výsledky31.12.2018
Poslední známé čtvrtletní výsledky30.09.2019
Počet zaměstnanců k 31.12.2018 50 000
Akcie v oběhu k 25.07.2019 510 555 869
Počet akcionářů k 31.12.2018 24 563
Konstituent indexůS&P 500
Kontaktní informace
Ulice1 Baxter Pkwy
ZeměUnited States
Kontatní osobaClare Trachtman
Funkce kontaktní osobyVice President, Investor Relations
Telefon18 479 482 000
Kontatní telefon12 249 483 085

Business Summary: Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. The Renal business offers a portfolio to meet the needs of patients with end-stage renal disease, or irreversible kidney disease and acute kidney injuries, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision.
Financial Summary: BRIEF: For the six months ended 30 June 2019, Baxter International Inc revenues decreased 1% to $5.47B. Net income before extraordinary items decreased 5% to $690M. Revenues reflect Americas segment decrease of 1% to $2.93B, EMEA segment decrease of 2% to $1.45B. Net income also reflects Americas segment income decrease of 5% to $1.12B, EMEA segment income decrease of 2% to $307M. Dividend per share increased from $0.35 to $0.41.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution - NEC
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
NAICSSurgical and Medical Instrument Manufacturing
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICSResearch and Development in the Physical, Engineering, and Life Sciences
SICSurgical And Medical Instruments
SICSurgical And Medical Instruments
SICElectromedical Equipment
SICPharmaceutical Preparations
SICCommercial Physical Research

  • Poslední aktualizace: 16.12.2019
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, President, Chief Executive OfficerJose Almeida5601.01.201601.01.2016
Chief Financial Officer, Executive Vice PresidentJames Saccaro46
Senior Vice President, Chief Accounting Officer, ControllerBrian Stevens4403.12.201803.12.2018
Senior Vice President, General CounselSean Martin5628.02.201728.02.2017
Senior Vice President - Human ResourcesJeanne Mason6315.05.2006
Senior Vice President, President - Global BusinessesGiuseppe Accogli4801.05.2017
Senior Vice President, President - AmericasBrik Eyre5501.01.2017
Senior Vice President and President, EMEACristiano Franzi5601.01.2017
Senior Vice President and President, APACAndrew Frye5301.01.2017
Senior Vice President - OperationsScott Pleau53